Vanguard Capital Management
MDT icon

Vanguard Capital Management’s Medtronic MDT Stock Holding History

Vanguard Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.56B Buy
83,816,735
+482,902
+0.6% +$39M 0.14% 112
2026
Q1 		$7.22B Buy
+83,333,833
New +$7.98B 0.18% 96

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Capital Management's MDT Position: Q2 2026 in Review

Vanguard Capital Management increased its Medtronic (MDT) stake by 0.58% in Q2 2026, buying an estimated $39M and bringing the position to 83,816,735 shares worth $6.56B. The position accounts for 0.14% of the portfolio, ranked #112.

Vanguard Capital Management first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.22B in Q1 2026. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vanguard Capital Management held 83,816,735 shares of Medtronic worth $6.56B as of Q2 2026.
  • Vanguard Capital Management bought 482,902 Medtronic shares in Q2 2026, an estimated $39M.
  • Medtronic made up 0.14% of Vanguard Capital Management's portfolio in Q2 2026, its #112 holding.
  • Vanguard Capital Management first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Medtronic position peaked at $7.22B in Q1 2026.
  • 2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.